Abstract
A new insulin derivative, mercaptobutyrimidyl pyridine disulfide insulin, was prepared under conditions which directed the reaction preferentially through the terminal alpha-amino group of the A-chain. The purified monosubstituted insulin exhibited only a marginal decrease in antigenicity as measured by radioimmunoassay; there was, however, a significant reduction in biological activity in the mouse convulsion assay. Conjugation of the insulin derivative to human placental alkaline phosphatase was carried out via a thiol interchange reaction and the resulting conjugate was active in a double-antibody, solid-phase enzyme immunoassay for insulin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
